Professional paper

https://doi.org/10.33004/reumatizam-67-1-4

WHEN TO SUSPECT AN AUTOINFLAMMATORY DISEASE?

Mario Šestan ; Division of Clinical Immunology
Marija Jelušić orcid.org/0000-0002-1728-4260 ; Division of Clinical Immunology,

Abstract

Autoinflammatory diseases are clinical disorders caused by a deficiency or dysregulation of innate immunity, characterized by recurrent or persistent inflammation (increased levels of acute phase reactants) and the absence of a primary pathogenic role of adaptive immunity (autoreactive T lymphocytes or antibody production). They are clinically manifested by recurrent episodes of systemic inflammation due to the activation of an intense nonspecific inflammatory reaction with no apparent or sufficient cause. In terms of pathogenesis, autoinflammatory diseases can be divided into monogenic, or those that are caused by a mutation in a well-defined gene, and non-monogenic, also referred to as unclassified. According to the three main pathogenic patterns of emergence in monogenic autoinflammatory diseases described to date, they are divided into inflammasomopathies, interferonopathies, and ubiquitinopathies. Clinically, inflammasomopathies are most commonly manifested by fever (often periodic type), rash, serositis, hepatosplenomegaly, and lymphadenopathy. The therapeutic approach in many of these diseases is based on the use of an interleukin-1 inhibitor. Interferonopathies are most commonly manifested as acral and lung vasculopathy and fibrosis, with an onset of skin changes like chilblains,
intracranial calcifications, and myositis. Janus kinase inhibitors are used in the treatment. Ubiquitinopathies are most commonly manifested by granuloma, ulceration, uveitis, and immunodeficiency. The therapeutic approach in these diseases is based on the use of tumor necrosis factor-alpha inhibitors. Unclassified autoinflammatory diseases include diseases that meet the clinical and biological criteria for autoinflammatory diseases but to date have no detected genetic background (for example, syndrome of periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis, Schnitzler syndrome, or systemic-onset juvenile idiopathic arthritis), and some multifactorial diseases that are polygenic or caused by complex interactions of multiple genes and environmental factors and not associated with Mendelian inheritance patterns (eg., gout, Behcet disease). In the diagnosis of patients with suspected autoinflammatory disease, it is necessary to exclude infections, malignancies, immunodeficiencies, and rheumatic diseases. The main indication for genetic testing is the presence of clinical symptoms that meet the criteria for one or more autoinflammatory diseases. There are a number of unanswered questions in genetic diagnostics, the main problem being the interpretation of the results.

Keywords

Hereditary autoinflammatory diseases – classification, diagnosis, genetics, therapy; Autoimmune diseases – diagnosis, immunology, therapy; Inflammation – immunology; Fever – genetics, immunology; Immunity, innate – immunology; Inflammasomes – immunology; Interferon type I – immunology; Ubiquitins – immunology; Interleukin-1 – antagonists and inhibitors; Janus kinase inhibitors – therapeutic use; Tumor necrosis factor-alpha – antagonists and inhibitors

Hrčak ID:

247879

URI

https://hrcak.srce.hr/247879

Publication date:

10.12.2020.

Article data in other languages: croatian

Visits: 4.360 *